Previous close | 21.25 |
Open | 21.30 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 90.00 |
Expiry date | 2024-06-21 |
Day's range | 21.25 - 21.30 |
Contract range | N/A |
Volume | |
Open interest | N/A |
CVS warns it could cede Medicare Advantage market share as reimbursement rates pressure the company.
Shares of CVS Health (CVS) are falling during Wednesday's trading session after the company revised its full-year guidance downward, citing mounting pressure from rising medical costs. The adjustment to the company's guidance comes on the heels of CVS's weaker-than-expected first quarter results, which missed estimates for both revenue and earnings. Yahoo Finance's Anjalee Khemlani breaks down the report. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith
CVS Health ( NYSE:CVS ) First Quarter 2024 Results Key Financial Results Revenue: US$88.4b (up 4.1% from 1Q 2023). Net...